Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 42
Filter
1.
Biochem Biophys Res Commun ; 496(1): 218-224, 2018 01 29.
Article in English | MEDLINE | ID: mdl-29307834

ABSTRACT

Previous studies show that gamma-glutamylcyclotransferase (GGCT) is expressed at high levels in various cancer tissues and that its knockdown inhibits MCF7 cancer cell growth via upregulation of p21WAF1/CIP1 (p21). However, the detailed underlying mechanism is unclear. Here, we used yeast two-hybrid screening and co-immunoprecipitation to identify Prohibitin-2 (PHB2) as a novel protein that interacts with GGCT. We also show that nuclear expression of PHB2 in MCF7 cells falls upon GGCT knockdown, and that overexpression of PHB2 inhibits p21 upregulation. A chromatin immunoprecipitation assay revealed that nuclear PHB2 proteins bind to the p21 promoter, and that this interaction is abrogated by GGCT knockdown. Moreover, knockdown of PHB2 alone led to significant upregulation of p21 and mimicked the cellular events induced by GGCT depletion, including G0/G1 arrest, cellular senescence, and growth inhibition, in a p21 induction-dependent manner. Taken together, the results indicate that PHB2 plays a central role in p21 upregulation following GGCT knockdown and as such may promote deregulated proliferation of cancer cells by suppressing p21.


Subject(s)
Cyclin-Dependent Kinase Inhibitor p21/metabolism , Neoplasms, Experimental/metabolism , Repressor Proteins/metabolism , gamma-Glutamylcyclotransferase/metabolism , Enzyme Activation , Gene Expression Regulation, Neoplastic , Humans , MCF-7 Cells , Prohibitins , Protein Binding , gamma-Glutamylcyclotransferase/genetics
2.
Int J Mol Sci ; 19(7)2018 Jul 14.
Article in English | MEDLINE | ID: mdl-30011933

ABSTRACT

γ-Glutamylcyclotransferase (GGCT), which is one of the major enzymes involved in glutathione metabolism, is upregulated in a wide range of cancers-glioma, breast, lung, esophageal, gastric, colorectal, urinary bladder, prostate, cervical, ovarian cancers and osteosarcoma-and promotes cancer progression; its depletion leads to the suppression of proliferation, invasion, and migration of cancer cells. It has been demonstrated that the suppression or inhibition of GGCT has an antitumor effect in cancer-bearing xenograft mice. Based on these observations, GGCT is now recognized as a promising therapeutic target in various cancers. This review summarizes recent advances on the mechanisms of the antitumor activity of GGCT inhibition.


Subject(s)
Alanine/therapeutic use , Enzyme Inhibitors/therapeutic use , Molecular Targeted Therapy/methods , Neoplasms/drug therapy , gamma-Glutamylcyclotransferase/antagonists & inhibitors , Alanine/analogs & derivatives , Enzyme Inhibitors/chemistry , Gene Expression Regulation, Enzymologic , Gene Expression Regulation, Neoplastic , Humans , MicroRNAs/genetics , Neoplasms/enzymology , Neoplasms/genetics , RNA Interference , gamma-Glutamylcyclotransferase/genetics , gamma-Glutamylcyclotransferase/metabolism
3.
BMC Cancer ; 16(1): 748, 2016 Sep 22.
Article in English | MEDLINE | ID: mdl-27658708

ABSTRACT

BACKGROUND: Chromosome 7 open reading frame 24 (C7orf24) was originally identified as a highly expressed protein in various types of cancer, and later shown to be a γ-glutamylcyclotransferase (GGCT). GGCT depletion in cancer cells has anti-proliferative effects in vitro and in vivo, and it is therefore considered a promising candidate as a therapeutic target. However, the cellular events induced by GGCT depletion remain unclear. METHODS: GGCT was depleted by siRNA in MCF7, MDA-MB-231, PC3, A172, Hela, and LNCaP cells. Induction of cellular senescence was evaluated with senescence-associated ß-galactosidase (SA-ß-Gal) staining. Expression levels of p21WAF1/CIP1 and p16INK4A were assessed by qRT-PCR and Western blotting. Effects of simultaneous double knockdown of p21WAF1/CIP1 and p16INK4A together with GGCT on cell cycle regulation and cell growth was measured by flow cytometry, and trypan blue dye exclusion test. RESULTS: We found that GGCT knockdown induces significant cellular senescence in various cancer cells. Cyclin dependent kinase inhibitor p21WAF1/CIP1 and/or p16INK4A were upregulated in all cell lines tested. Simultaneous knockdown of p21WAF1/CIP1 recovered the cell cycle arrest, attenuated cellular senescence induction, and rescued the subsequent growth inhibition in GGCT-silenced MCF7 breast cancer cells. In contrast, in GGCT silenced MDA-MB-231 breast cancer cells, GGCT depletion upregulated p16INK4A, which played a regulatory role in senescence induction, instead of p21WAF1/CIP1. CONCLUSIONS: Our findings demonstrate that induction of cellular senescence mediated by the upregulation of cyclin-dependent kinase inhibitors is a major event underlying the anti-proliferative effect of GGCT depletion in breast cancer cells, highlighting the potential of GGCT blockade as a therapeutic strategy to induce cellular senescence.

4.
Chem Pharm Bull (Tokyo) ; 64(7): 785-92, 2016.
Article in English | MEDLINE | ID: mdl-27373633

ABSTRACT

γ-Glutamylcyclotransferase (GGCT) is an important enzyme that cleaves γ-glutamyl-amino acid in the γ-glutamyl cycle to release 5-oxoproline and amino acid. Eighteen N-acyl-L-alanine analogues including eleven new compounds have been synthesized and examined for their inhibitory activity against recombinant human GGCT protein. Simple N-glutaryl-L-alanine was found to be the most potent inhibitor for GGCT. Other N-glutaryl-L-alanine analogues having methyl and dimethyl substituents at the 2-position were moderately effective, while N-(3R-aminoglutary)-L-alanine, the substrate having an (R)-amino group at the 3-position or N-(N-methyl-3-azaglutaryl)-L-alanine, the substrate having an N-methyl substituent on the 3-azaglutaryl carbon, in constract, exhibited excellent inhibition properties.


Subject(s)
Alanine/analogs & derivatives , Alanine/chemical synthesis , Enzyme Inhibitors/chemical synthesis , Enzyme Inhibitors/pharmacology , gamma-Glutamylcyclotransferase/antagonists & inhibitors , Alanine/chemistry , Alanine/pharmacology , Dose-Response Relationship, Drug , Enzyme Inhibitors/chemistry , Humans , Molecular Structure , Structure-Activity Relationship , gamma-Glutamylcyclotransferase/metabolism
5.
Org Biomol Chem ; 13(11): 3182-5, 2015 Mar 21.
Article in English | MEDLINE | ID: mdl-25651484

ABSTRACT

Cancer-related γ-glutamyl cyclotransferase (GGCT) specifically converts γ-glutamyl amino acids (γ-Glu-Xaa) into pyroglutamate and the corresponding amino acids (Xaa). Here we report a novel GGCT fluorogenic probe "LISA-101" containing a masked O-acylated fluorophore "resorufin" on the side chain of the P amino acid (Xaa). Upon GGCT treatment, the P amino acid was liberated and spontaneously released the intact fluorophore. Thus, the fluorescence was regained. LISA-101 will expand the strategies for cancer studies.


Subject(s)
Antibodies, Monoclonal , Fluorescent Dyes , Neoplasms/diagnosis , gamma-Glutamylcyclotransferase , Antibodies, Monoclonal/chemistry , Antibodies, Monoclonal/metabolism , Cell Line, Tumor , Fluorescent Dyes/chemical synthesis , Fluorescent Dyes/metabolism , Humans , MCF-7 Cells , Molecular Structure , gamma-Glutamylcyclotransferase/chemical synthesis , gamma-Glutamylcyclotransferase/metabolism
6.
Int J Urol ; 22(7): 621-8, 2015 Jul.
Article in English | MEDLINE | ID: mdl-25944546

ABSTRACT

In all creatures including humans, the molecules that function in accordance with the genetic code are mainly proteins. After completing the sequencing of the human genome, rapid progress has been made in proteome analysis. The primary structures of almost all proteins were determined by the human genome sequence. However, the whole picture of proteins cannot be elucidated because of alternative splicing and post-translational modifications. Therefore, genomic as well as systematic and comprehensive information of proteins is required. Modern methods of proteomics have dramatically improved the quality and speed of protein analysis. Developments in both bioinformatics and mass spectrometry have contributed to the technical improvement, making it possible to identify proteins in a short time with high accuracy even from a very small sample. In the field of cancer research, many studies of useful diagnostic and prognostic biomarkers using these proteomic technologies have been reported, and target molecules for treatment have been explored. The aim of the present review was to summarize the basic technologies of proteomics and recent research in the field of urothelial cancer obtained using proteomic methods.


Subject(s)
Biomarkers, Tumor , Carcinoma, Transitional Cell/diagnosis , Proteome/metabolism , Proteomics/methods , Urologic Neoplasms/diagnosis , Carcinoma, Transitional Cell/metabolism , Computational Biology , Humans , Mass Spectrometry , Urologic Neoplasms/metabolism
7.
Chembiochem ; 14(16): 2110-3, 2013 Nov 04.
Article in English | MEDLINE | ID: mdl-24115556

ABSTRACT

Light it up: human chromosome 7 ORF 24, a tumor-related protein, has been identified as a γ-glutamyl cyclotransferase (GGCT) in the glutathione homeostasis cycle. The singular substrate preference of the enzyme has hampered chemical probe development, and no fluorogenic probe has been reported. Here we report the first fluorogenic dipeptide probe, LISA-4, which should contribute toward further understanding of GGCT.


Subject(s)
Fluorescent Dyes/metabolism , Nitrogen/metabolism , Oxygen/metabolism , gamma-Glutamylcyclotransferase/metabolism , Binding Sites , Biocatalysis , Chromosomes, Human, Pair 7 , Dipeptides/chemistry , Dipeptides/metabolism , Fluorescent Dyes/chemistry , Humans , Molecular Docking Simulation , Nitrogen/chemistry , Open Reading Frames , Oxygen/chemistry , Protein Structure, Tertiary , gamma-Glutamylcyclotransferase/genetics
9.
Hinyokika Kiyo ; 56(1): 25-8, 2010 Jan.
Article in Japanese | MEDLINE | ID: mdl-20104006

ABSTRACT

We report a case of renal arteriovenous fistula (RAVF) following blunt renal trauma. An 84-year-old woman who presented with massive gross hematuria after striking her right flank region on the corner of a table was transferred to neighboring hospital on October 24, 2006. Plain computerized tomography (CT) revealed a small subcapsular hematoma on the right kidney, corresponding to a type I renal injury according to the classification of the Japanese Association for the Surgery of Trauma. However, subsequent enhanced CT demonstrated the migration of injected contrast material from the main trunk of the right renal artery to the inferior vena cava in the early phases. Because these findings suggested the occurrence of RAVF, the patient was referred to our hospital for further evaluation and therapy. Selective right renal arteriography enabled observation of trauma-induced RAVF in the upper pole of the affected kidney. Consecutively, transcatheter arterial embolization was performed with a metal coil, after which the shunt blood flow was successfully stopped. RAVF associated with blunt renal injury is extremely rare : only four cases have been previously reported in the literature.


Subject(s)
Arteriovenous Fistula/etiology , Kidney/injuries , Renal Artery , Renal Veins , Wounds, Nonpenetrating/complications , Accidental Falls , Aged, 80 and over , Arteriovenous Fistula/diagnostic imaging , Arteriovenous Fistula/therapy , Embolization, Therapeutic , Female , Humans , Renal Artery/diagnostic imaging , Renal Veins/diagnostic imaging , Tomography, X-Ray Computed
11.
Int J Urol ; 16(5): 481-6, 2009 May.
Article in English | MEDLINE | ID: mdl-19389084

ABSTRACT

OBJECTIVES: To evaluate the potential suitability of calreticulin (CRT) as a urinary marker for bladder cancer. METHODS: Urine specimens were collected from patients with histologically confirmed bladder urothelial carcinoma (Group 1; n = 109), urological patients without urothelial carcinoma (Group 2; n = 60), and non-urological patients (Group 3; n = 40). We developed an enzyme-linked immunosorbent assay (ELISA) procedure using commercially available anti-CRT mono/polyclonal antibodies, and then measured the concentration of urinary CRT. RESULTS: Urinary CRT concentration of group 1 was significantly higher than group 2 and 3 (Mann-Whitney U-test, P < 0.001). Groups 2 and 3 were joined together and considered as a non-bladder cancer group (n = 100), and a cutoff value (2.85 ng/mL) was determined using receiver operating characteristic (ROC) analysis. The sensitivity, specificity, and the area under the curve were 67.9%, 80.0%, and 0.742, respectively. The overall sensitivity of voided urine cytology (VUC) was 39.0% (n = 105), and the sensitivity of urinary CRT was significantly superior to VUC (McNemar test, P < 0.001). Higher sensitivity was observed especially in Ta, G1-2, and

Subject(s)
Biomarkers/urine , Calreticulin/urine , Enzyme-Linked Immunosorbent Assay/methods , Urinary Bladder Neoplasms/diagnosis , Urinary Bladder Neoplasms/urine , Aged , Aged, 80 and over , Area Under Curve , Diagnostic Techniques, Urological , Enzyme-Linked Immunosorbent Assay/standards , Female , Humans , Male , Middle Aged , Predictive Value of Tests , ROC Curve , Sensitivity and Specificity , Urothelium
12.
J Clin Invest ; 115(4): 978-85, 2005 Apr.
Article in English | MEDLINE | ID: mdl-15761500

ABSTRACT

The mainstay in the management of invasive bladder cancer continues to be radical cystectomy. With regard to improvement of quality of life, however, therapies that preserve the bladder are desirable. We investigated the use of intravesical PLK-1 small interfering RNA (siRNA) against bladder cancer. Patients with bladder cancers expressing high levels of PLK-1 have a poor prognosis compared with patients with low expression. Using siRNA/cationic liposomes, the expression of endogenous PLK-1 could be suppressed in bladder cancer cells in a time- and dose-dependent manner. As a consequence, PLK-1 functions were disrupted. Inhibition of bipolar spindle formation, accumulation of cyclin B1, reduced cell proliferation, and induction of apoptosis were observed. In order to determine the efficacy of the siRNA/liposomes in vivo, we established an orthotopic mouse model using a LUC-labeled bladder cancer cell line, UM-UC-3(LUC). PLK-1 siRNA was successfully transfected into the cells, reduced PLK-1 expression, and prevented the growth of bladder cancer in this mouse model. This is the first demonstration, to our knowledge, of inhibition of cancer growth in the murine bladder by intravesical siRNA/cationic liposomes. We believe intravesical siRNA instillation against bladder cancer will be useful as a therapeutic tool.


Subject(s)
Cell Cycle Proteins/genetics , Cell Cycle Proteins/metabolism , Protein Kinases/genetics , Protein Kinases/metabolism , Proto-Oncogene Proteins/genetics , Proto-Oncogene Proteins/metabolism , RNA, Small Interfering/administration & dosage , Urinary Bladder Neoplasms/therapy , Administration, Intravesical , Animals , Antineoplastic Agents/administration & dosage , Antineoplastic Agents/therapeutic use , Apoptosis , Cell Line, Tumor , Cystectomy , Gene Expression Regulation, Enzymologic , Gene Expression Regulation, Neoplastic , Humans , Liposomes/therapeutic use , Mice , Mice, Inbred BALB C , Protein Serine-Threonine Kinases , RNA, Small Interfering/metabolism , RNA, Small Interfering/therapeutic use , Urinary Bladder/cytology , Urinary Bladder/metabolism , Urinary Bladder/pathology , Urinary Bladder Neoplasms/genetics , Urinary Bladder Neoplasms/pathology , Polo-Like Kinase 1
13.
Hinyokika Kiyo ; 54(9): 633-5, 2008 Sep.
Article in Japanese | MEDLINE | ID: mdl-18975581

ABSTRACT

Priapism is rare and usually unpredictable. High-flow priapism is caused by unregulated arterial inflow. Antecedent trauma is the most commonly described etiology. This condition does not require emergent treatment. The initial management of high-flow priapism should be observation, because treatment-related erectile dysfunction may appear. We report a case of high-flow priapism by perineal trauma in a 27-year-old man. His corpora were typically tumescent, but not completely rigid. He could not have sexual intercourse. Blood from the corpus cavernosum was normally oxygenated. Color duplex ultrasonography was performed in the lithotomy position, scanned at the perineum, showed pseudoaneurysmal appearance. Selective internal pudendal arteriography showed a right cavernous arterial extravasation. Superselective embolization of right internal pudendal arteries was performed with an autologous clot. After the procedure, detumescence was achieved as well as erectile function. We recommend superselective arterial embolization as the management of high flow priapism to patients who request treatment.


Subject(s)
Embolization, Therapeutic/methods , Penis/blood supply , Perineum/injuries , Priapism/etiology , Priapism/therapy , Adult , Humans , Male , Penile Erection , Perineum/blood supply , Priapism/physiopathology , Regional Blood Flow , Treatment Outcome
14.
Am J Cancer Res ; 8(4): 650-661, 2018.
Article in English | MEDLINE | ID: mdl-29736310

ABSTRACT

Gamma-glutamylcyclotransferase (GGCT) was originally identified as a protein highly expressed in bladder cancer tissues by proteomic analysis, and its higher expression in a variety of cancers compared to normal tissues have been shown. Depletion of GGCT in various cancer cells results in antiproliferative effects both in vitro and in vivo; thus it is considered a promising therapeutic target. Although it has been shown that knockdown of GGCT induces cellular senescence and non-apoptotic cell death, associated with upregulation of cyclin-dependent kinase inhibitors (CDKIs) including p21WAF1/CIP1, the cellular events that follow GGCT depletion are not fully understood. Here, we show that GGCT depletion induced autophagy in MCF7 breast and PC3 prostate cancer cells. Conversely, overexpression of GGCT in NIH3T3 fibroblast under conditions of serum deprivation inhibited autophagy and increased proliferation. Simultaneous knockdown of autophagy related-protein 5, a critical effector of autophagy, along with GGCT in MCF7 and PC3 cells led to significant attenuation of the multiple cellular responses, including upregulation of CDKIs, increased numbers of senescence-associated ß-galactosidase positive senescent cells, and growth inhibition. Furthermore, we show that autophagy-promoting signaling cascades including activation of the AMPK-ULK1 pathway and/or inactivation of the mTORC2-Akt pathway were triggered in GGCT-depleted cells. These results indicate that autophagy plays an important role in the growth inhibition of cancer cells caused by GGCT depletion.

15.
ChemMedChem ; 13(2): 155-163, 2018 01 22.
Article in English | MEDLINE | ID: mdl-29316360

ABSTRACT

γ-Glutamylcyclotransferase (GGCT) depletion inhibits cancer cell proliferation. However, whether the enzymatic activity of GGCT is critical for the regulation of cancer cell growth remains unclear. In this study, a novel diester-type cell-permeable prodrug, pro-GA, was developed based on the structure of N-glutaryl-l-alanine (GA), by structure optimization using temporary fluorophore-tagged prodrug candidates. The antiproliferative activity of pro-GA was demonstrated using GGCT-overexpressing NIH-3T3 cells and human cancer cells including MCF7, HL-60, and PC3 cells. By contrast, normal cells were not significantly affected by pro-GA treatment. Moreover, pro-GA administration exhibited anticancer effects in a xenograft model using immunocompromised mice inoculated with PC3 cells. These results indicate that the enzymatic activity of GGCT accelerates tumor growth and that GGCT inhibition is a promising therapeutic strategy for the treatment of GGCT-overexpressing tumors.


Subject(s)
Antineoplastic Agents/pharmacology , Cell Proliferation/drug effects , Dipeptides/pharmacology , Prodrugs/pharmacology , Prostatic Neoplasms/drug therapy , gamma-Glutamylcyclotransferase/antagonists & inhibitors , Alanine/analogs & derivatives , Alanine/chemistry , Alanine/pharmacology , Alanine/therapeutic use , Animals , Antineoplastic Agents/chemistry , Antineoplastic Agents/therapeutic use , Cell Line , Cell Line, Tumor , Dipeptides/chemistry , Dipeptides/therapeutic use , Glutarates/chemistry , Glutarates/pharmacology , Glutarates/therapeutic use , Heterografts , Humans , Male , Mice, SCID , Prodrugs/chemistry , Prodrugs/therapeutic use , Structure-Activity Relationship , gamma-Glutamylcyclotransferase/metabolism
16.
Hinyokika Kiyo ; 52(10): 809-15, 2006 Oct.
Article in Japanese | MEDLINE | ID: mdl-17131874

ABSTRACT

Small cell carcinoma (SCC) originating from the prostate is rare. We report three cases of SCC of the prostate. Case 1: A 29-year-old man with large pelvic mass and pelvic lymph node metastases was diagnosed as having pure SCC of the prostate. Chemo-radiotherapy resulted in a great reduction of the tumor volume. However, the disease recurred immediately, and he died of disease 17 months after diagnosis. Case 2: A 65-year-old man presented with pure prostatic SCC with lung metastases. Although cystoprostatectomy combined with pre- and post-operative chemotherapy ended with no evidence of disease, he died after 16 months because of multiple metastases and local recurrence. Case 3: A 73-year-old man was diagnosed as having SCC and poorly differentiated adenocarcinoma of the prostate simultaneously. Chemo-endocrine therapy and pelvic irradiation were performed, achieving partial remission. However, he developed multiple distant metastases, and died of disease 15 months after diagnosis. We reviewed 82 cases previously reported in Japan. Patient's ages ranged from 24 to 86 years (mean 68.7 years). Many patients had lymph node or distant metastases (stage D, 73%). Thirty-seven (45%) were pure SCCs and 45 (55%) were associated with adenocarcinoma. The prognosis after the recognition of SCC is very poor, and the 1- and 2-year survival rates were 27% and 10%, respectively. Survival did not differ in patients with pure SCC or mixed glandular and small cell carcinoma. Higher elevation of pretreatment serum NSE value was associated with the poor prognosis.


Subject(s)
Carcinoma, Small Cell/secondary , Prostatic Neoplasms/pathology , Adult , Aged , Carcinoma, Small Cell/diagnosis , Fatal Outcome , Humans , Magnetic Resonance Imaging , Male , Neoplasm Metastasis , Prognosis , Prostatic Neoplasms/diagnosis , Survival Analysis
17.
Oncol Rep ; 13(4): 597-600, 2005 Apr.
Article in English | MEDLINE | ID: mdl-15756429

ABSTRACT

Angiogenesis in the growth and development of prostate cancer was the focus of this study. Various angiogenic factors and their clinicopathologic correlations with the progression of prostate cancer have been examined. Thymidine phosphorylase is identical to platelet-derived endothelial cell growth factor (TP/PD-ECGF) and has angiogenic activity. We investigated the expression of TP/PD-ECGF in prostate cancer and its association with angiogenesis or clinicopathologic findings in 81 cases with prostate cancer. Western blot analysis using a specific monoclonal antibody 654-1 revealed the existence of a 55 kDa TP/PD-ECGF protein in human prostate cancer tissue. Cancer tissue showed low-positive immunostaining in 32 cases (39.5%) and high positivity in 49 cases (60.5%). This protein expression indicated a statistically significant association with microvessel density (low vs. high TP/PD-ECGF expression group: mean +/- SD, 37.3+/-27.0 vs. 53.1+/-28.0 microvessels in three fields, p<0.05). No correlation was found between the expression of TP/PD-ECGF and nuclear grade, glandular differentiation, clinical stage or overall survival rate. TP/PD-ECGF may play an important role in tumor angiogenesis in prostate cancer tissues. Although the expression of TP/PD-ECGF was not correlated with clinical outcome in patients with prostate cancer, there remains the possibility that TP/PD-ECGF may support or modify the tumor growth through angiogenesis in cooperation with other factors.


Subject(s)
Microcirculation , Prostatic Neoplasms/blood supply , Prostatic Neoplasms/enzymology , Thymidine Phosphorylase/biosynthesis , Aged , Aged, 80 and over , Antibodies, Monoclonal/chemistry , Blotting, Western , Cell Line, Tumor , Humans , Immunohistochemistry , Male , Middle Aged , Neovascularization, Pathologic , Treatment Outcome
18.
Biomed Res Int ; 2015: 345219, 2015.
Article in English | MEDLINE | ID: mdl-26339607

ABSTRACT

Gamma-glutamylcyclotransferase (GGCT) is one of the major enzymes involved in glutathione metabolism. However, its gene locus was unknown for many years. Recently, the gene for GGCT was found to be identical to C7orf24, which is registered as a hypothetical protein. Orthologs have been found in bacteria, plants, and nematodes as well as higher organisms, and the GGCT gene is highly preserved among a wide range of species. GGCT (C7orf24) was also reported as an upregulated protein in various cancers. Although the function of GGCT in cancer cells has not been determined, the following important activities have been reported: (1) high expression in various cancer tissues and cancer cell lines, (2) low expression in normal tissues, (3) inhibition of cancer cell proliferation via anti-GGCT RNAi, (4) inhibition of cancer cell invasion and migration via anti-GGCT RNAi, (5) an epigenetic transcriptional regulation in cancer cells, and (6) an antitumor effect in cancer-bearing xenograft mice. Therefore, GGCT is promising as a diagnostic marker and a therapeutic target for various cancers. This review summarizes these interesting findings.


Subject(s)
Biomarkers, Tumor/genetics , Glutathione/metabolism , Neoplasms/genetics , gamma-Glutamylcyclotransferase/genetics , Animals , Biomarkers, Tumor/biosynthesis , Cell Proliferation/genetics , Gene Expression Regulation, Neoplastic , Humans , Mice , Neoplasm Invasiveness/genetics , Neoplasms/enzymology , Neoplasms/pathology , RNA Interference , gamma-Glutamylcyclotransferase/biosynthesis
19.
Adv Exp Med Biol ; 539(Pt A): 33-46, 2003.
Article in English | MEDLINE | ID: mdl-15088894

ABSTRACT

BACKGROUND: Uroplakins (UPs), urothelium-specific transmembrane proteins, are present only in urothelia and may be good candidates as tumor markers specific for transitional cell carcinomas (TCCs). We investigated the expression of UP genes in the tissues and peripheral blood of patients with TCCs. MATERIALS AND METHODS: We determined the nucleotide sequences of UPs by a polymerase chain reaction (PCR)-based method. We then investigated UP gene expression in tissues from 12 patients with TCC by reverse transcription (RT)-PCR. We also investigated UP gene expression in peripheral blood of 12 other patients with TCC by nested RT-PCR. Polyclonal and monoclonal antibodies against UPs were generated using synthesized polypeptides and recombinant protein, respectively, as immunogens. RESULTS: We determined the nucleotide sequence of human UP-Ib, UP-II, and UP-III cDNAs and produced gene-specific primer pairs for each and for UP-Ia. UP genes were expressed in both cancerous and non-cancerous urothelia taken from all patients examined (as detected by RT-PCR). The detection sensitivity of our assay system was such that 1 cancer cell could be detected in 5 mL of peripheral blood. UP gene-expression was also detected in the peripheral blood of 3 patients with metastatic TCC, but not from 9 patients with non-metastatic TCC or from 3 healthy volunteers. Antibodies against both UP-Ia and UP-Ib reacted with the cell membrane of TCCs. CONCLUSIONS: UPs may be employed as tumor markers for TCCs, because they are highly conserved and well expressed in non-cancerous and cancerous cells. Furthermore, detection of UP gene expression in blood by nested RT-PCR may provide helpful information in the diagnosis and management of TCCs. We are currently expanding an immunohistochemical study by targeting a larger number of patients to examine the clinical usefulness of these antibodies.


Subject(s)
Carcinoma, Transitional Cell/genetics , Gene Expression Regulation, Neoplastic , Membrane Glycoproteins/genetics , Urinary Bladder Neoplasms/genetics , Adult , Aged , Amino Acid Sequence , Animals , Antibodies , Base Sequence , Cloning, Molecular , Female , Humans , Male , Membrane Glycoproteins/immunology , Membrane Proteins/genetics , Membrane Proteins/immunology , Mice , Mice, Inbred BALB C , Middle Aged , Molecular Sequence Data , Polymerase Chain Reaction , Tetraspanins , Uroplakin II , Uroplakin III , Uroplakin Ia , Uroplakin Ib , Urothelium/physiology
20.
Hinyokika Kiyo ; 49(9): 547-50, 2003 Sep.
Article in Japanese | MEDLINE | ID: mdl-14598695

ABSTRACT

A 56-year-old woman was admitted to our hospital for treatment of right stone pyonephrosis with a perirenal abscess. After right nephrectomy for the pyonephrosis, the patient suffered from post-operative bleeding, which was stopped by closing off the drain tube with a clamp. However, a right retroperitoneal abscess with gas formation developed nine days after the operation, necessitating an operative procedure for drainage. Pus culture revealed Staphylococcus epidermidis and Candida albicans. Discharge from the drain tube became dark green days after the drainage procedure. Upper gastrointestinal series revealed a duodenal fistula, which could not be closed using a retroperitoneal approach, so the operative wound was left open. Because of the volume of discharge (800-1,400 ml/day), somatostatin analogue, 100 micrograms, was injected subcutaneously twice a day. Discharge decreased by one-half within 2 weeks of the administration of somatostatin analogue. However, the duodenocutaneous fistula had not resolved over a period of 8 months. Since the patient developed acute cholecystitis, both cholecystectomy and closure of the duodenocutaneous fistula were performed transperitoneally. The duodenocutaneous fistula, which was closed with Endo GIA (35 mm), had protruded from a descending portion of the duodenum like the diverticulum. The postoperative course was uneventful. We speculated that the fistula occurred as a result of the inflammation with the abscess formation.


Subject(s)
Cutaneous Fistula/etiology , Duodenal Diseases/etiology , Intestinal Fistula/etiology , Nephrectomy , Postoperative Complications , Pyelonephritis/surgery , Cutaneous Fistula/therapy , Duodenal Diseases/therapy , Female , Humans , Intestinal Fistula/therapy , Kidney Calculi/complications , Middle Aged , Pyelonephritis/complications
SELECTION OF CITATIONS
SEARCH DETAIL